Madeleine Pharmaceuticals, Inc.

CHANHASSEN, MN 55317

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $2MM
First Award Date 05/01/16
Most Recent Award Date 05/01/16

Key Personnel

Last Name Name Awards Contact
BERRYMAN LEIGH BERRYMAN 1

1 Award Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 05/01/16 - 04/30/17

? DESCRIPTION (provided by applicant): The Specific Aim of this direct to Phase II proposal is to carry out IND enabling work for our drug, Vastiras(r). Our first therapeutic target patient population is the ~400,000 people who suffer from acute decompensated heart failure (ADCHF or AHF) and present with renal compromise. These patients are ho...